BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 9, 2003
View Archived Issues
Mice Stripped Of Dysferlin Protein Got Muscular Dystrophy, Not Able To Vulcanize Pierced Musculature
Read More
Americans Wary Of Prescription Drugs Coming In From Canada
Read More
Innodia Licenses Diabetes Product From Neurochem, Closes Series A
Read More
Other News To Note
Read More
Guilford Licenses Inhibitor Class To Pfizer As Part Of Broad Deal
Guilford Pharmaceuticals Inc. is licensing an entire class of potential neurodegenerative disease drugs to Pfizer Inc. for $5 million up front in a deal that could become much more lucrative down the road. (BioWorld Today)
Read More
PDL's Asthma Therapy Fizzles; Expected After Nuvance Failure
Read More
